Goldline Pharmaceutical Limited

Goldline Pharmaceutical Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials and compliance.
CIN U51397MH2004PLC147806 Incorporated 02 August 2004 ROC Mumbai HQ Nagpur, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹28.06 Cr
▲ 19.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹13.5 Cr
Registered with MCA
Paid-up capital
₹8.71 Cr
Issued & subscribed
Open charges
₹8.54 Cr
Satisfied ₹3.53 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
85
Latest available

About Goldline Pharmaceutical Limited

Data last updated: 07 January 2026

Goldline Pharmaceutical Limited is a public limited company based in Nagpur, Maharashtra, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 02 August 2004, the company has been in operation for over 22 years.

Registered with ROC Mumbai under CIN U51397MH2004PLC147806.

Capital: an authorised share capital of ₹13.5 Cr and a paid-up capital of ₹8.71 Cr. Formerly known as Goldline Pharmaceutical Private Limited. It is led by directors including Swapan Khandelwal and Amol Laxmikant Mujumdar.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Nagpur, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹28.06 Cr, a growth of 19% compared to the previous year.

The company has a workforce of approximately 85 employees as per the latest available data.

As per MCA filings, the company has open charges of ₹8.54 Cr and satisfied charges of ₹3.53 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website goldlinepharma.in.

Company Details of Goldline Pharmaceutical Limited
CIN U51397MH2004PLC147806
Registration Number 147806
Incorporation Date 02 August 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    103 F – 1Leelaapartmentshilpahsgsociety Nearsaptagirinagar Shanidham Narend, Ra Nagar, Nagpur, Maharashtra, India – 440015
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Goldline Pharmaceutical Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Goldline Pharmaceutical Limited report

Financials, compliance, directors, charges, ownership and filings for Goldline Pharmaceutical Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Goldline Pharmaceutical Limited

Goldline Pharmaceutical Limited has one previous CIN (Corporate Identification Number): U51397MH2004PTC147806. The current CIN is U51397MH2004PLC147806, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U51397MH2004PLC147806 Current
U51397MH2004PTC147806 Previous

Business Activity of Goldline Pharmaceutical Limited

Goldline Pharmaceutical Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Goldline Pharmaceutical Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Goldline Pharmaceutical Limited

Goldline Pharmaceutical Limited is audited by SHAH & RAUT for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
SHAH & RAUT Locked Locked Locked
Premium access

Complete auditor history for Goldline Pharmaceutical Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Goldline Pharmaceutical Limited

Goldline Pharmaceutical Limited is currently managed by 8 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Swapan Khandelwal Whole-Time Director 11 Apr 2011 15 Years 4 Months Current
Amol Laxmikant Mujumdar Managing Director 02 Aug 2004 22 Years 0 Months Current
Mehul Hari Ranade Director 30 Sep 2024 1 Years 10 Months Current
Prashant Shrikrishna Karkare Director 16 Jul 2013 13 Years 1 Months Current
Renuka Saurabh Borole Director 30 Sep 2024 1 Years 10 Months Current
Shraddha Kiran Kulkarni Director 17 Oct 2024 1 Years 10 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Goldline Pharmaceutical Limited FY 2025 filings available

Goldline Pharmaceutical Limited reported revenue of ₹28.06 Cr (up 19.00% YoY) for FY 2025.

Revenue · FY 2025
₹28.06 Cr ▲ 19.00%
Premium access

Ten-year financial statements for Goldline Pharmaceutical Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Goldline Pharmaceutical Limited

Premium access

Shareholding and ownership data for Goldline Pharmaceutical Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Goldline Pharmaceutical Limited

Open charges
₹8.54 Cr
Satisfied charges
₹3.53 Cr
Breakdown by lending institutions
Bank of India₹8.11 Cr
Others₹0.42 Cr
Latest charge details
DateLenderAmountStatus
12 Dec 2024 Others ₹42.1 Lakh Open
02 May 2022 Bank of India ₹46 Lakh Open
16 Jan 2013 Bank of India ₹7.65 Cr Open
27 Dec 2013 Bank of India ₹8 Lakh Satisfied
17 Feb 2011 State Bank of India ₹3.45 Cr Satisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Goldline Pharmaceutical Limited

Goldline Pharmaceutical Limited has a workforce of 85 employees as of Apr 07, 2024.

Employee count
85
Active EPFO establishments
1
Employee growth
-19.81%
Premium access

Employee and EPFO history for Goldline Pharmaceutical Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Goldline Pharmaceutical Limited

Premium access

GST registrations and filing compliance for Goldline Pharmaceutical Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Goldline Pharmaceutical Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Goldline Pharmaceutical Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Goldline Pharmaceutical Limited

Premium access

MSME payment history for Goldline Pharmaceutical Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Goldline Pharmaceutical Limited

Premium access

Corporate group structure for Goldline Pharmaceutical Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Goldline Pharmaceutical Limited

Premium access

MCA filings and documents for Goldline Pharmaceutical Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Goldline Pharmaceutical Limited

Activity
30 Sep 2025
Goldline Pharmaceutical Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Goldline Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
17 Jan 2025
Dipti Sharad Bhusari was appointed as a Cfo on 17 Jan 2025 & has been associated with this company since 1 year 7 months.
Charges
12 Dec 2024
A charge with Others amounted to Rs. 0.42 Cr with Charge ID 101015954 was registered on 12 Dec 2024.
Charges
05 Dec 2024
A charge registered on 27 Dec 2013 via Charge ID 100814496 with Bank Of India was fully satisfied on 05 Dec 2024.
Directors
05 Nov 2024
Ruchi Sanket Modi was appointed as a Company Secretary on 05 Nov 2024 & has been associated with this company since 1 year 9 months.

Frequently Asked Questions about Goldline Pharmaceutical Limited

Goldline Pharmaceutical Limited is an active public limited company in the pharma sector based in Nagpur, Maharashtra, India. It was incorporated on 02 August 2004 (22+ years old) and is registered under CIN U51397MH2004PLC147806. The company has 85 employees.

Goldline Pharmaceutical Limited reported revenue of ₹28.06 Cr for FY 2025 (up 19.00% YoY).

The current directors of Goldline Pharmaceutical Limited are:

The primary industry of Goldline Pharmaceutical Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Goldline Pharmaceutical Limited can be reached at the registered office: 103 F – 1Leelaapartmentshilpahsgsociety Nearsaptagirinagar Shanidham Narend, Ra Nagar, Nagpur, Maharashtra, India – 440015, or through the website goldlinepharma.in.

The authorised capital is ₹13.5 Cr, and the paid-up capital is ₹8.71 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available